SomaLogic's 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe.
BOULDER, Colo. and L'AQUILA, Italy, July 24, 2023 /PRNewswire/ -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante Genomics, a global leader in genomics and precision medicine, to offer a comprehensive solution for proteomics testing at scale in Europe. Dante will be the first SomaLogic authorized site in Italy.
Read more at prnewswire.com